Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The 2017 issue emphasized progress in laser and energy-based skin treatments, but noted the need for more research on certain procedures and technologies.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Hair loss is significantly linked to symptoms like dry hair, scalp issues, addiction to tobacco or coffee, anxiety, and digestive problems.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

Myrtle has various health benefits and potential for medicine development.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

New single-cell analysis techniques are improving our understanding of stem cells and could help in treating diseases.

Photographic documentation crucial for evaluating hair growth in androgenetic alopecia.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

A mutation in the KRT75 gene causes frizzle feathers in chickens.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.